355 results match your criteria: "David Geffen UCLA School of Medicine[Affiliation]"
PLoS One
May 2014
Division of Cancer Research and Training, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America ; Department of Internal Medicine, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America ; Charles R. Drew University of Medicine and Science, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America ; Jonsson Comprehensive Cancer Center and David Geffen UCLA School of Medicine, Los Angeles, California, United States of America.
Background: African-American women have higher mortality from breast cancer than other ethnic groups. The association between poor survival and differences with tumor phenotypes is not well understood. The purpose of this study is to assess the clinical significance of (1) Stem cell-like markers CD44 and CD24; (2) PI3K/Akt pathway associated targets PTEN, activation of Akt, and FOXO1; and (3) the Insulin-like growth factor-1 (IGF-I) and IGF binding protein-3 (IGFBP3) in different breast cancer subtypes, and compare the differences between African-American and Hispanic/Latina women who have similar social-economic-status.
View Article and Find Full Text PDFClin Cancer Res
October 2013
Authors' Affiliations: Laboratory of Molecular Pathology, Ludwig Institute for Cancer Research; Moores Cancer Center; University of California San Diego, La Jolla; Celgene Corporation, San Diego; Department of Neurological Surgery and Brain Tumor Research Center, University of California at San Francisco, San Francisco; California Institute of Technology, Pasadena; Henry Singleton Brain Tumor Program; Jonsson Comprehensive Cancer Center; Department of Neurology, David Geffen UCLA School of Medicine; Department of Molecular and Medical Pharmacology; UCLA Medical Scientist Training Program, University of California, Los Angeles, Los Angeles, California; Celgene Corporation, Summit, New Jersey; Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center and Arthur G. James Cancer Hospital, Columbus, Ohio; Department of Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, Verona, Italy; INSERM; Metabolomics Platform, Institut Gustave Roussy, Villejuif; Université Paris Descartes/Sorbonne Paris Cité; Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers; and Pôle de Biologie, Hôpital Européen Georges Pompidou, Paris, France.
Purpose: mTOR pathway hyperactivation occurs in approximately 90% of glioblastomas, but the allosteric mTOR inhibitor rapamycin has failed in the clinic. Here, we examine the efficacy of the newly discovered ATP-competitive mTOR kinase inhibitors CC214-1 and CC214-2 in glioblastoma, identifying molecular determinants of response and mechanisms of resistance, and develop a pharmacologic strategy to overcome it.
Experimental Design: We conducted in vitro and in vivo studies in glioblastoma cell lines and an intracranial model to: determine the potential efficacy of the recently reported mTOR kinase inhibitors CC214-1 (in vitro use) and CC214-2 (in vivo use) at inhibiting rapamycin-resistant signaling and blocking glioblastoma growth and a novel single-cell technology-DNA Encoded Antibody Libraries-was used to identify mechanisms of resistance.
J Acquir Immune Defic Syndr
January 2014
*Department of Pediatrics, Boston University School of Medicine, Boston, MA; †Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD; ‡HIV/AIDS Research Department, Irmandade da Santa Casa de Misericordia de Porto Alegre, Rio Grande do Sul, Brazil; §Department of Pediatrics, David Geffen UCLA School of Medicine, Los Angeles, CA; ‖Malawi College of Medicine, Blantyre, Malawi; ¶Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janiero, Brazil; #Department of Pediatrics, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; **Serviço de Infectologia, Hospital Nossa Senhora da Conceicao, Porto Alegre, Rio Grande do Sul, Brazil; ††Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; ‡‡Gilead Sciences, Foster City, CA; §§Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ‖‖Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD; ¶¶Family Health International, Durham, NC; ##Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda; ***National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and †††Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD.
Background: Data describing the pharmacokinetics and safety of tenofovir in neonates are lacking.
Methods: The HIV Prevention Trials Network 057 protocol was a phase 1, open-label study of the pharmacokinetics and safety of tenofovir disoproxil fumarate (TDF) in HIV-infected women during labor and their infants during the first week of life with 4 dosing cohorts: maternal 600 mg doses/no infant dosing; no maternal dosing/infant 4 mg/kg doses on days 0, 3, and 5; maternal 900 mg doses/infant 6 mg/kg doses on days 0, 3, and 5; maternal 600 mg doses/infant 6 mg/kg daily for 7 doses. Pharmacokinetic sampling was performed on cohort 1 and 3 mothers and all infants.
Eur Spine J
April 2015
Department of Radiology, David Geffen UCLA School of Medicine, Los Angeles, USA.
Purpose: To outline the pathogenesis of cervical spondylotic myelopathy (CSM), the correlative abnormalities observed on standard magnetic resonance imaging (MRI), the biological implications and current status of diffusion tensor imaging (DTI), and MR spectroscopy (MRS) as clinical tools, and future directions of MR technology in the management of CSM patients.
Methods: A systematic review of the pathogenesis and current state-of-the-art in MR imaging technology for CSM was performed.
Results: CSM is caused by progressive, degenerative, vertebral column abnormalities that result in spinal cord damage related to both primary mechanical and secondary biological injuries.
Chest
October 2013
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY. Electronic address:
Background: COPD and heart failure with preserved ejection fraction overlap clinically, and impaired left ventricular (LV) filling is commonly reported in COPD. The mechanism underlying these observations is uncertain, but may include upstream pulmonary dysfunction causing low LV preload or intrinsic LV dysfunction causing high LV preload. The objective of this study is to determine if COPD and emphysema are associated with reduced pulmonary vein dimensions suggestive of low LV preload.
View Article and Find Full Text PDFContinuum (Minneap Minn)
June 2013
Department of Neurology, David Geffen-UCLA School of Medicine, 710 Westwood Plaza, Los Angeles, CA 90095, USA.
Purpose Of Review: The purpose of this review is to provide an evidence-based update on the neurostimulation options available for patients with drug-resistant epilepsy in the United States and in European countries.
Recent Findings: The field of neurostimulation for epilepsy has grown dramatically since 1997, when vagus nerve stimulation became the first device to be approved for epilepsy by the US Food and Drug Administration (FDA). New data from recently completed randomized controlled trials are available for deep brain stimulation of the anterior thalamus, responsive neurostimulation, and trigeminal nerve stimulation.
J Vasc Surg
March 2013
David Geffen UCLA School of Medicine, University of California, Los Angeles, CA, USA.
Heart
May 2013
Cedars-Sinai Medical Center, Cedars-Sinai Heart Institute, David Geffen UCLA School of Medicine, Los Angeles, CA 90048, USA.
Mol Cytogenet
February 2013
Clinical Molecular Cytogenetics Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.
The t(8;14)(q24.1;q32), the cytogenetic hallmark of Burkitt's lymphoma, is also found, but rarely, in cases of chronic lymphocytic leukemia (CLL). Such translocation typically results in a MYC-IGH@ fusion subsequently deregulating and overexpressing MYC on der 14q32.
View Article and Find Full Text PDFJ Assoc Genet Technol
June 2015
Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine. Los Angeles, CA.
Chronic myelogenous leukemia (CML) is characterized by the specific cytogenetic translocation t(9;22)(q34;q11.2), also called the Philadelphia (Ph) chromosome. We present a case of a cryptic BCR/ABL1 fusion, which was not originally detected by standard karyotyping.
View Article and Find Full Text PDFExp Hematol Oncol
August 2012
Department of Pathology & Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, 90095, USA.
T-cell prolymphocytic leukemia (T-PLL) is a rare form of leukemia composed of mature T-cells that usually presents in older people with a median age of 65. Most cases of T-PLL will harbor chromosomal abnormalities involving 14q11.2 (TCR alpha/delta), 14q32 (TCL1) or Xq28 (MTCP-1), abnormalities of chromosome 8, 12p and deletions of the long arm of chromosomes 5, 6, 11 and 13.
View Article and Find Full Text PDFWorld Psychiatry
October 2012
Department of Psychiatry and Biobehavioral Sciences, David Geffen-UCLA School of Medicine; Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA, USA.
Cell Metab
June 2012
Departments of Pathology and Laboratory Medicine and Molecular and Medical Pharmacology, The David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA.
Cancer cells in culture obtain ATP and biosynthetic precursors primarily by aerobic glycolysis, not by mitochondrial glucose oxidation. In this issue of Cell Metabolism, Marin-Valencia et al. (2012) demonstrate that glioblastoma, an aggressive and, in culture, highly glycolytic cancer, primarily uses glucose oxidation to meet energetic and biosynthetic demands in vivo.
View Article and Find Full Text PDFPediatrics
June 2012
Department of Pediatrics, Division of Infectious Diseases, David Geffen UCLA School of Medicine, MDCC 22-442, 10833 LeConte Ave, Los Angeles, CA 90095, USA.
Background And Objective: The impact of maternal antiretrovirals (ARVs) during pregnancy, labor, and postpartum on infant outcomes is unclear.
Methods: Infants born to HIV-infected mothers in ARV studies were followed for 18 months.
Results: Between June 2006 and December 2008, 236 infants enrolled from Africa (n = 36), India (n = 47), Thailand (n = 152), and Brazil (n = 1).
Ann N Y Acad Sci
February 2012
David Geffen/UCLA School of Medicine, Department of Pathology and Laboratory Medicine, and Human Genetics, Los Angeles, California 90095-1732, USA.
Within less than 10 years after the realization of the double helix of DNA, the ability of aminoglycosides to influence the misreading or readthrough of premature termination codons was discovered. It took another three decades to clone and sequence disease genes and appreciate the similarity of mutation spectra for most inborn errors. Nonsense mutations once again have become the target of readthrough compounds.
View Article and Find Full Text PDFJ Support Oncol
July 2012
Department of Psychiatry and Palliative Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.
Ann Thorac Surg
January 2012
Ronald Reagan UCLA Medical Center, David Geffen UCLA School of Medicine, University of California, Los Angeles, Los Angeles, California 90095, USA.
Background: The Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS) have intermittently surveyed their combined membership. These manpower surveys have provided snapshots of thoracic surgery, documenting practice changes over time. At this critical time in US health care reform the physician workforce is of critical importance.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
January 2012
Ronald Reagan UCLA Medical Center, David Geffen UCLA School of Medicine, University of California, Los Angeles, Los Angeles, California 90095, USA.
Background: The Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS) have intermittently surveyed their combined membership. These manpower surveys have provided snapshots of thoracic surgery, documenting practice changes over time. At this critical time in US health care reform the physician workforce is of critical importance.
View Article and Find Full Text PDFInt J Pediatr Endocrinol
August 2011
Division of Pediatric Endocrinology, Cedars-Sinai Medical Center, David Geffen-UCLA School of Medicine 8700 Beverly Blvd,, Rm 4220, Los Angeles, CA 90048, USA.
PCOS, a heterogeneous disorder characterized by cystic ovarian morphology, androgen excess, and/or irregular periods, emerges during or shortly after puberty. Peri- and post-pubertal obesity, insulin resistance and consequent hyperinsulinemia are highly prevalent co-morbidities of PCOS and promote an ongoing state of excess androgen. Given the relationship of insulin to androgen excess, reduction of insulin secretion and/or improvement of its action at target tissues offer the possibility of improving the physical stigmata of androgen excess by correction of the reproductive dysfunction and preventing metabolic derangements from becoming entrenched.
View Article and Find Full Text PDFJ Pediatr Orthop
September 2011
David Geffen UCLA School of Medicine, Chula Vista, CA, USA.
Background: Poliomyelitis in children can cause paralysis of shoulder girdle muscles leading to a flail shoulder. Shoulder arthrodesis is indicated as a possible treatment for these children in order to stabilize the shoulder. This retrospective study reviewed all shoulder arthrodesis surgeries owing to complications of polio performed at a major medical institution between 1981 and 1996 to assess position of fusion, radiographic evidence of fusion, complications, and patient satisfaction.
View Article and Find Full Text PDFInt Urogynecol J
December 2011
Division of Female Pelvic Medicine and Reconstructive Surgery, David Geffen UCLA School of Medicine, 1000 W. Carson St, Torrance, CA 90509, Box 489, USA.
Introduction And Hypothesis: The objective of this study was to determine the predictors of successful treatment of lower urinary tract disorders with sacral nerve stimulation (SNS) and the rate of adverse events and reoperations.
Methods: A retrospective case series of patients who underwent SNS at a single institution was analyzed.
Results: Seventy-six patients underwent stage I trial of SNS.
JAMA
July 2011
RAND Corporation and David Geffen UCLA School of Medicine, 1776 Main St, Santa Monica, CA 90401, USA.
Clin Cancer Res
January 2011
Department of Neurology, David Geffen UCLA School of Medicine, Los Angeles, California 90095-1732, USA.
Cancer is a molecularly complex, genomically unstable disease. Selection for drug-resistant mutations, activation of feedback loops, and upregulation of cross-talk pathways provide escape routes by which cancer cells maintain signal flux through critical downstream effectors to promote therapeutic resistance. Attempts to target signal transduction pathways in cancer may therefore require investigators to aim at a moving target.
View Article and Find Full Text PDFAIDS
November 2010
Division of Infectious Diseases, David Geffen UCLA School of Medicine, Los Angeles, California 90095, USA.
Objectives: To evaluate the effect of extended antenatal triple antiretroviral therapy (ART) on infant outcomes.
Design: Retrospective cohort study using pooled data from health clinics in Malawi and Mozambique from July 2005 to December 2009.
Methods: Computerized records of 3273 HIV-infected pregnant women accessing Drug Resource Enhancement Against AIDS and Malnutrition centers were reviewed.